Ignite Creation Date:
2025-12-24 @ 6:44 PM
Ignite Modification Date:
2025-12-30 @ 7:12 AM
Study NCT ID:
NCT03720457
Status:
UNKNOWN
Last Update Posted:
2021-08-31
First Post:
2018-10-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Human CD19 Targeted T Cells Injection(CD19 CAR-T) Therapy for Relapsed and Refractory CD19-positive Lymphoma.
Sponsor:
Hrain Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-11-13
Start Date Type:
ACTUAL
Primary Completion Date:
2021-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-10
Completion Date Type:
ESTIMATED
First Submit Date:
2018-10-24
First Submit QC Date:
None
Study First Post Date:
2018-10-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-29
Last Update Post Date:
2021-08-31
Last Update Post Date Type:
ACTUAL